Principal
Navigare VenturesCheck size: Navigare Ventures does not publish one standard current check-size range on its official website.
Elin Almstedt invests or supports investment decisions through Navigare Ventures's published strategy: Transform scientific excellence into globally important companies by investing in research-based deep technology and life sciences from early commercialization onward.
Defensible science, world-class research teams, clear commercial applications and technologies with the potential to create large industrial or health outcomes.
No formal pass list is public. Conventional businesses without research depth, scientific differentiation or a credible commercialization path appear less aligned.
Present the scientific breakthrough, validation, intellectual-property position, commercialization route, team and milestones required to cross from research into a scalable company.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Elin Almstedt is a current Principal at Navigare Ventures, according to the firm's official roster. No prior employer, education or personal portfolio is inferred where the firm does not publish a biography.